Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice.

Saved in:

Bibliographic Details
Title:	Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice.
Authors:	Bisgaard LS; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.; Global Research, Novo Nordisk, Måløv, Denmark., Bosteen MH; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Biochemistry, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark., Fink LN; Global Research, Novo Nordisk, Måløv, Denmark., Sørensen CM; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark., Rosendahl A; Global Research, Novo Nordisk, Måløv, Denmark., Mogensen CK; Global Research, Novo Nordisk, Måløv, Denmark., Rasmussen SE; Global Research, Novo Nordisk, Måløv, Denmark., Rolin B; Global Research, Novo Nordisk, Måløv, Denmark., Nielsen LB; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Biochemistry, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark., Pedersen TX; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Source:	PloS one [PLoS One] 2016 Dec 16; Vol. 11 (12), pp. e0168396. Date of Electronic Publication: 2016 Dec 16 (Print Publication: 2016).
Publication Type:	Journal Article
Journal Info:	Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1932-6203
DOI:	10.1371/journal.pone.0168396